STOCK TITAN

Eastman Chemical (NYSE: EMN) director receives 1,628-share restricted stock award

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Eastman Chemical Company director Linnie M. Haynesworth received an annual equity grant in the form of restricted common shares. On May 7, 2026, she acquired 1,628 shares at no cash price as a grant or award, increasing her direct holdings to 3,135 shares. These are restricted shares, with restrictions scheduled to lapse on May 7, 2027, subject to conditions related to her continued service as a director. The share amount represents her annual Restricted Stock Award, reflecting routine director compensation rather than an open-market purchase or sale.

Positive

  • None.

Negative

  • None.
Insider Haynesworth Linnie M
Role null
Type Security Shares Price Value
Grant/Award Common Stock 1,628 $0.00 --
Holdings After Transaction: Common Stock — 3,135 shares (Direct, null)
Footnotes (1)
  1. [object Object]
Restricted shares granted 1,628 shares Common Stock grant on May 7, 2026
Grant price $0.0000 per share Equity award, no cash consideration
Shares after transaction 3,135 shares Total direct holdings following grant
Vesting date May 7, 2027 Restrictions on restricted stock lapse, subject to conditions
Restricted shares financial
"Restricted shares, with restrictions lapsing on May 7, 2027, subject to certain conditions"
Restricted shares are company stock that cannot be sold or transferred immediately because they are subject to legal or contractual limits, such as a required holding period or performance conditions. They matter to investors because these locked-up shares can affect a company’s available stock for trading, future dilution, and insider incentives—imagine a gift that can’t be cashed until certain conditions are met, which changes when and how much supply can suddenly enter the market.
Restricted Stock Award financial
"The share amounts represent the director's annual Restricted Stock Award."
A restricted stock award is company shares given to an employee or executive that cannot be sold or fully owned until certain conditions—like staying with the company for a set time or hitting performance targets—are met. Think of it as a gift that only becomes yours after you fulfill specific obligations; for investors, these awards matter because they can increase the total shares outstanding when they vest, reveal how management is being paid and motivated, and create potential selling pressure when restrictions lift.
continued service as a director financial
"subject to certain conditions related to continued service as a director."
Grant, award, or other acquisition financial
"transaction_code_description": "Grant, award, or other acquisition""
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Haynesworth Linnie M

(Last)(First)(Middle)
200 S. WILCOX DRIVE

(Street)
KINGSPORT TENNESSEE 37660

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
EASTMAN CHEMICAL CO [ EMN ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/07/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock05/07/2026A1,628A$03,135(1)D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Restricted shares, with restrictions lapsing on May 7, 2027, subject to certain conditions related to continued service as a director. The share amounts represent the director's annual Restricted Stock Award.
Remarks:
/s/ Mark D. Austin, by Power of Attorney for Linnie M. Haynesworth05/11/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Eastman Chemical (EMN) report for Linnie M. Haynesworth?

Eastman Chemical reported that director Linnie M. Haynesworth received a grant of 1,628 shares of common stock on May 7, 2026. The shares were awarded at no cash price as part of her annual Restricted Stock Award for board service.

Were Linnie M. Haynesworth’s new Eastman Chemical (EMN) shares an open-market purchase?

No, the 1,628 Eastman Chemical shares were granted as restricted stock, not bought on the open market. They represent her annual Restricted Stock Award and are part of routine director compensation rather than a discretionary stock purchase.

When do Linnie M. Haynesworth’s restricted Eastman Chemical (EMN) shares vest?

The restrictions on Linnie M. Haynesworth’s restricted shares are scheduled to lapse on May 7, 2027. Vesting is subject to certain conditions related to her continued service as a director on Eastman Chemical’s board through that date.

How many Eastman Chemical (EMN) shares does Linnie M. Haynesworth hold after this grant?

Following the May 7, 2026 grant of 1,628 restricted shares, Linnie M. Haynesworth directly holds a total of 3,135 Eastman Chemical common shares. This figure reflects her position after including the newly awarded restricted stock.

What is the nature of the equity compensation granted to Eastman Chemical (EMN) director Haynesworth?

The filing describes the award as restricted shares representing the director’s annual Restricted Stock Award. These shares are subject to forfeiture conditions, with restrictions lapsing on May 7, 2027, contingent on her continued service on Eastman Chemical’s board.